Mayur Narkhede

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Monoclonal Antibody

Top Venues

Future oncology (London, England)

Expert review of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, Weimin Liu, Regina M Stoltz, Allisa K Oman, Lucinda A Hall, Ran Li, Sarah Sterrett, Ellen R Frederick, Jeffrey R Lancaster, Mayur Narkhede, Amitkumar Mehta, Foluso J Ogunsile, Rima B Patel, Thomas J Ketas, Victor M Cruz Portillo, Albert Cupo, Benjamin M Larimer, Paul A Goepfert, Paul A Goepfert, Beatrice H Hahn, Randall S Davis
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study. PLoS medicine 20 (6) (2023)
Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, Weimin Liu, Regina M Stoltz, Allisa K Oman, Lucinda A Hall, Ran Li, Sarah Sterrett, Ellen R Frederick, Jeffrey R Lancaster, Mayur Narkhede, Amitkumar Mehta, Foluso J Ogunsile, Rima B Patel, Thomas J Ketas, Victor M Cruz Portillo, Albert Cupo, Benjamin M Larimer, Paul A Goepfert, Paul A Goepfert, Beatrice H Hahn, Randall S Davis
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study. PLoS medicine 20 (6) (2023)
Mayur Narkhede, Nancy L Bartlett, Sami Ibrahimi, Leslie Popplewell, Anna Seto, Jamie Bates, Yeonju Lee, Vaishnavi Ganti, Ling Han, Tianling Chen, Manish R Patel
A phase 1 first-in-human study of GS-0189, an anti-signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL). EJHaem 4 (2) (2023)
Mayur Narkhede, Nancy L Bartlett, Sami Ibrahimi, Leslie Popplewell, Anna Seto, Jamie Bates, Yeonju Lee, Vaishnavi Ganti, Ling Han, Tianling Chen, Manish R Patel
A phase 1 first-in-human study of GS-0189, an anti-signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL). EJHaem 4 (2) (2023)
Mayur Narkhede, Nancy L Bartlett, Sami Ibrahimi, Leslie Popplewell, Anna Seto, Jamie Bates, Yeonju Lee, Vaishnavi Ganti, Ling Han, Tianling Chen, Manish R Patel
A phase 1 first-in-human study of GS-0189, an anti-signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL). EJHaem 4 (2) (2023)
Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, Weimin Liu, Regina M Stoltz, Allisa K Oman, Lucinda A Hall, Ran Li, Sarah Sterrett, Ellen R Frederick, Jeffrey R Lancaster, Mayur Narkhede, Amitkumar Mehta, Foluso J Ogunsile, Rima B Patel, Thomas J Ketas, Victor M Cruz Portillo, Albert Cupo, Benjamin M Larimer, Paul A Goepfert, Paul A Goepfert, Beatrice H Hahn, Randall S Davis
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study. PLoS medicine 20 (6) (2023)
Mayur Narkhede, Gaurav Goyal, Lauren Shea, Amit Mehta, Smith Giri
Evaluating real-world treatment patterns and outcomes of mantle cell lymphoma. Blood advances 6 (14) (2022)
Mayur Narkhede, Bruce D Cheson
Copanlisib in the treatment of non-Hodgkin lymphoma. Future oncology (London, England) 16 (26) (2020)
Mayur Narkhede, Maryam Sarraf Yazdy, Bruce D Cheson
Determining the sequence of novel therapies in the treatment of relapsed Hodgkin's lymphoma. Expert review of hematology 11 (10) (2018)